Press Releases
KEFEA’s position on the drugs pricing system
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) expresses the belief that the change in the pricing policy for medicines, as has been approved by Cabinet, ensures, under the circumstances, the continued availability of the majority...
Creation of a Cypriot network for research and innovation. European IMI programme.
The foundation for creating a network for research and innovation in Cyprus has been set by the meeting for the European Innovative Medicines Initiative (IMI) programme, held on July 3, at the Cyprus Institute of Neurology and Genetics. With a budget of €2 billion,...
KEFEA is strong supporter of GESY
The Cyprus Association of Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) commends the decision of the Cabinet to approve the implementation proposal of a National Health System (GESY) in Cyprus, which was presented by the Ministry of...
We cordially invite you to the first Innovative Medicines Initiative Information Day in Cyprus that will take place on Tuesday July 3rd, at the Amphitheatre of the Cyprus Institute of Neurology and Genetics (6 International Airport Avenue Nicosia) from 2.00 – 5.00 p.m.
Please download the Agenda and Invitation. IMI Info Day July 3rd invitation The Minister of Health Dr Stavros Malas, will address the event. The info meeting is specially addressed to interested parties from the pharmaceutical industry, academia, small and...
Innovative Medicines Initiative meeting in Cyprus
€2 bln for research programmes An informative meeting, which aims to promote Cypriot participation in the present and future calls of the European Innovative Medicines Initiative (IMI) project, the submission of research proposals and the creation of an IMI network in...
KEFEA requests complete information regarding the investigation of the Pharmaceutical Services.
The recent findings made public from the comparative study prepared by the Pharmaceutical Services of the Ministry of Health for the pricing of drugs in Cyprus have caused great concern. The Cyprus Association of Pharmaceutical Research and Development Companies...
KEFEA sounds the alarm on pharmaceuticals
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) has been following with great concern the sudden change in policy on behalf of the Ministry of Health, in relation to the application of contracts for the purchase of medications....
Improving the Reference Mechanism While Ensuring Meaningful Referencing
Key Messages: The current country basked correctly reflects the socio-economic level of Cyprus The economic situation of Greece is not comparable with Cyprus A better implementation of the current P&R mechanism can improve affordability of medicines for patients'...
Commissioners on research and innovation in Cyprus.
In a separate meeting, Minister of Finance and EFPIA General Director stressed the importance of implementing a universal health system in Cyprus that will enhance innovation and research and improve healthcare. The industry expressed its commitment to contribute to...
EFPIA Director General Richard Bergstrom in Cyprus IMI and Cyprus EU Presidency will be discussed with the Minister of Health
Richard Bergstrom, Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) is visiting Cyprus on the 10th of May to attend a meeting with the Minister of Health for discussions regarding the implementation of the Innovative...